We observed that the mRNA and protein expression of BRD4 has no significant difference among breast cancer subtypes5, however, the high expression of miR-548d-3p in the BLBC subtype suggests that some other factors, besides BRD4, might determine its particular expression status. This evidence concerns the gene BRD4 and breast cancer.